68 related articles for article (PubMed ID: 35396116)
1. Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity.
Meneses D; Olveira A; Corripio R; Méndez MDC; Romero M; Calvo-Viñuelas I; Herranz L; Vicent D; de-Cos-Blanco AI
Endocrinol Diabetes Nutr (Engl Ed); 2022 Mar; 69(3):178-188. PubMed ID: 35396116
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes.
Lembo E; Russo MF; Verrastro O; Anello D; Angelini G; Iaconelli A; Guidone C; Stefanizzi G; Ciccoritti L; Greco F; Sessa L; Riccardi L; Pompili M; Raffaelli M; Vecchio FM; Bornstein SR; Mingrone G; Gastaldelli A; Capristo E
Diabetes Metab; 2022 Sep; 48(5):101363. PubMed ID: 35760372
[TBL] [Abstract][Full Text] [Related]
3. Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.
Ayres ABS; Carneiro CRG; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2024 Feb; 34(2):456-466. PubMed ID: 38097891
[TBL] [Abstract][Full Text] [Related]
4. Compare the Combined Diagnostic Accuracy of Transient Elastography and Visual Liver Score in Assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Compare it with Liver Biopsy in Morbidly Obese Patients Undergoing Bariatric Surgery: An Observational Study.
Sharma D; Anand G; Meena S; Bhardwaj V
Obes Surg; 2024 Apr; 34(4):1247-1256. PubMed ID: 38411879
[TBL] [Abstract][Full Text] [Related]
5. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study.
Theel WB; Boxma-de Klerk BM; Dirksmeier-Harinck F; van Rossum EF; Kanhai DA; Apers JA; van Dalen BM; De Knegt RJ; Neecke B; van der Zwan EM; Grobbee DE; Hankemeier T; Wiebolt J; Castro Cabezas M
BMJ Open; 2023 Jul; 13(7):e070431. PubMed ID: 37400234
[TBL] [Abstract][Full Text] [Related]
6. Fibrotic NASH in Individuals with Obesity: a Cross-sectional Analysis of the Prevalence of this Significant Milestone of Disease Progression and Accuracy of a Non-invasive Marker for its Screening.
de Souza Echeverria L; Mounzer DLS; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2024 Feb; 34(2):389-395. PubMed ID: 38110785
[TBL] [Abstract][Full Text] [Related]
7. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.
Rivière B; Jaussent A; Macioce V; Faure S; Builles N; Lefebvre P; Géraud P; Picot MC; Rebuffat S; Renard E; Paradis V; Servais MD; de Preville N; Nocca D; Lajoix AD; Pageaux GP; Galtier F;
Diabetes Metab; 2022 Jul; 48(4):101345. PubMed ID: 35339664
[TBL] [Abstract][Full Text] [Related]
8. Periodontal and Hepatic Parameters in Obese Patients Undergoing Bariatric Surgery.
Čolak D; Pintar T; Cmok Kučič A; Salobir J; Gašpirc B; Gašperšič R
Oral Health Prev Dent; 2022 Jun; 20(1):295-304. PubMed ID: 35866675
[TBL] [Abstract][Full Text] [Related]
9. Serum Ferritin and NAFLD in Patients Undergoing Bariatric Surgery.
Giacomazzi CB; Tovo CV; Moreira TR; Pase THS; Linhares AB; Coral GP; Rinaldi N; Pioner SR; De Carli LA; Fontes PRO
Obes Surg; 2022 Aug; 32(8):2658-2663. PubMed ID: 35670949
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery.
Abdalla TSA; Giannou AD; Abdalla ASA; Izbicki JR; Dupreé A; Mann O; Wolter S
World J Surg; 2023 Dec; 47(12):3281-3288. PubMed ID: 37747548
[TBL] [Abstract][Full Text] [Related]
11. Significant fibrosis assessed by liver biopsy among Chinese bariatric surgery patients: A prospective cross-sectional study.
Huang Y; Dong S; Wang C; Dong Z; Chen W
Front Endocrinol (Lausanne); 2023; 14():1090598. PubMed ID: 36793287
[TBL] [Abstract][Full Text] [Related]
12. Development, Validation, and Application of a Scoring Model for Non-alcoholic Steatohepatitis.
Xiao J; Zhang X; Zhu C; Gu Y; Sun L; Liang X; He Q
Obes Surg; 2023 Oct; 33(10):3246-3255. PubMed ID: 37644345
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency.
Luger M; Kruschitz R; Kienbacher C; Traussnigg S; Langer FB; Schindler K; Würger T; Wrba F; Trauner M; Prager G; Ludvik B
Obes Surg; 2016 Oct; 26(10):2425-32. PubMed ID: 26989059
[TBL] [Abstract][Full Text] [Related]
14. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.
Hatto M; Ivano VK; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
Obes Surg; 2023 May; 33(5):1580-1586. PubMed ID: 37004688
[TBL] [Abstract][Full Text] [Related]
15. Histological findings and NAFLD/NASH Status in liver biopsies of patients subjected to bariatric surgery.
Malucelli M; Strobel R; Ivantes C; Sakamoto D; Luís Duarte M; Lucia Alves Pedroso M
Arch Endocrinol Metab; 2023 Nov; 68():e220138. PubMed ID: 37948562
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic Bariatric Treatment with Duodenal-Jejunal Bypass Liner Improves Non-invasive Markers of Non-alcoholic Steatohepatitis.
Karlas T; Petroff D; Feisthammel J; Beer S; Blüher M; Schütz T; Lichtinghagen R; Hoffmeister A; Wiegand J
Obes Surg; 2022 Aug; 32(8):2495-2503. PubMed ID: 35713854
[TBL] [Abstract][Full Text] [Related]
17. The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods.
Meneses D; Olveira A; Corripio R; Méndez MD; Romero M; Calvo-Viñuelas I; González-Pérez-de-Villar N; de-Cos-Blanco AI
Obes Surg; 2022 Aug; 32(8):2682-2695. PubMed ID: 35697996
[TBL] [Abstract][Full Text] [Related]
18. Insulin Resistance Is the Main Characteristic of Metabolically Unhealthy Obesity (MUO) Associated with NASH in Patients Undergoing Bariatric Surgery.
Schmitz SM; Storms S; Koch A; Stier C; Kroh A; Rheinwalt KP; Schipper S; Hamesch K; Ulmer TF; Neumann UP; Alizai PH
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371690
[TBL] [Abstract][Full Text] [Related]
19. Association of C-reactive protein with histological, elastographic, and sonographic indices of non-alcoholic fatty liver disease in individuals with severe obesity.
Jamialahmadi T; Bo S; Abbasifard M; Sathyapalan T; Jangjoo A; Moallem SA; Almahmeed W; Ashari S; Johnston TP; Sahebkar A
J Health Popul Nutr; 2023 Apr; 42(1):30. PubMed ID: 37029427
[TBL] [Abstract][Full Text] [Related]
20. Links between gut microbiome, metabolome, clinical variables and non-alcoholic fatty liver disease severity in bariatric patients.
Schwenger KJP; Sharma D; Ghorbani Y; Xu W; Lou W; Comelli EM; Fischer SE; Jackson TD; Okrainec A; Allard JP
Liver Int; 2024 May; 44(5):1176-1188. PubMed ID: 38353022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
